Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.58
+0.20 (2.71%)
Apr 2, 2026, 12:23 PM EDT - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $745.81 million as of April 2, 2026. Its market cap has increased by 79.54% in one year.
Market Cap
745.81M
Enterprise Value
559.44M
1-Year Change
79.54%
Ranking
Category
Stock Price
$7.58
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $745.81M, a decrease of -1.10%. That is a compound annual growth rate of -0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 708.40M | 61.22% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 722.54M |
| BridgeBio Oncology Therapeutics | 715.49M |
| Alto Neuroscience | 702.80M |
| Vor Biopharma | 698.36M |
| Relmada Therapeutics | 696.47M |
| Jade Biosciences | 690.92M |
| MeiraGTx Holdings | 690.66M |
| Arvinas | 679.27M |